Premium Information is available for this item - Upgrade for $1 a day
6550-01-643-0455
Tig2 Antibody
6550016430455 016430455 SC-373797
January 2023
1

Marketplace 6550-01-643-0455
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-643-0455 3+ Documents (More...)
6550-01-643-0455 3+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-643-0455
/fsg-65/fsc-6550/us 6550-01-643-0455 /fsg-65/fsc-6550/us 6550-01-643-0455 /fsg-65/fsc-6550/us 6550-01
Tig2 Antibody 6550016430455 016430455 01-643-0455 3+ Documents ( More... ) https//www.nsnlookup.com
/fsg-65/fsc-6550/us 6550-01-643-0455 Tig2 888-4727 /fsg-66/fsc-6675/ca 6675-21 https//www.nsnlookup.com
Tig2 Antibody 6550016430455 016430455 for $1 a day Upgrade your Account Upgrade 6550-01-643-0455Tig2
Antibody6550016430455 016430455 SC-373797 us 6550-01-643-0455 /fsg-65/fsc-6550/us 6550-01 https//www.nsnlookup.com
Restrictions 6550-01-643-0455
6550-01-643-0455 is a Tig2 Antibody Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
End Users 6550-01-643-0455
- Turkey (ZW01)
- Effective Date:
- 1 Mar 2015
Approved Sources 6550-01-643-0455
- Part Number
- Manufacturer
- Status
- SC-373797
- Manufacturer
- 1FAA0 - Santa Cruz Biotechnology Inc (Active)
- Primary Buy
- Primary Buy
NATO Stock Numbers Related to 6550-01-643-0455
Freight Information 6550-01-643-0455
6550-01-643-0455 has freight characteristics managed by Turkey.. 6550-01-643-0455 has a variance between NMFC and UFC when transported by rail and the description should be consulted.